NDC 66689-031-01 - Metoclopramide Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-031
- Requested NDC
- 66689-031-01
- Package NDCs from labels
- 66689-031-01, 66689-031-50
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide Hydrochloride - VistaPharm, LLC | VistaPharm, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66689-031-50 | 2024-01-30 | C162847 | 48780-1 | 1030e365-276c-111a-e063-dadaa90a10e2 | METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-031-01 | ML - Milliliter | 66689-031 | 21c6cdb2-83f7-412d-beb1-8dd49b4ba7f3 | 1 | 2013-02-13 |
| 66689-031-50 | ML - Milliliter | 66689-031 | 7ec00a6a-fe58-4173-80a2-fd83172446f1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Metoclopramide Hydrochloride | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| Metoclopramide | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R A2I8C7HI9T |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R A2I8C7HI9T |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R A2I8C7HI9T |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona | FERULIC ACID, VITAMIN C, DMAE | ANUBIS COSMETICS SL | eaf0770c-795d-0232-e053-2a95a90ae0b5 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | 059QF0KO0R A2I8C7HI9T |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R A2I8C7HI9T |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Liverex I | GINKGO BILOBA, FEL TAURI, GALLBLADDER (SUIS), HEPAR SUIS), THYROIDINUM (SUIS), GERMANIUM SESQUIOXIDE, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, MANGANUM METALLICUM, PYRUVIC ACID, SUCCINICUM ACIDUM, NAPHTHOCHINONUM, ARSENICUM METALLICUM, SULPHUR, ACONITICUM ACIDUM, CIS, LYCOPODIUM CLAVATUM, NATRUM OXALACETICUM, PHOSPHORUS | Energique, Inc. | 1c23c489-0a43-4736-a30a-0ae02c09fb45 | 2023-07-21 | Warnings | XF417D3PSL |
| REFL HS | ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) | Deseret Biologicals, Inc. | 2fe2d3c1-1829-4a33-be8e-2bad52546f36 | 2023-07-17 | Warnings | XF417D3PSL |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Fresenius Kabi USA, LLC | cc739885-e10e-4bcb-a781-c726c518f3d1 | 2023-06-07 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| LY-CO | ANGELICA ARCHANGELICA, KALI MURIATICUM, YUCCA FILAMENTOSA, CARTILAGO SUIS, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, RHUS TOX, CAUSTICUM, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, OXALICUM ACIDUM, ARNICA MONTANA, BORRELIA BURGDORFERI NOSODE, LATRODECTUS MACTANS, CITRICUM ACIDUM, CYTOMEGALOVIRUS NOSODE, RICKETTSIA NOSODE (RICKETTSIA PROWAZEKII), CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE | Bhp Holdings, Inc. | 47140966-5b49-432d-bf35-bcae14f42082 | 2023-06-01 | Warnings | XF417D3PSL |
| Lyme and Co-Infection Nosode | ANGELICA ARCHANGELICA, KALI MURIATICUM, YUCCA FILAMENTOSA, CARTILAGO SUIS, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, RHUS TOX, CAUSTICUM, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, OXALICUM ACIDUM, ARNICA MONTANA, BABESIA MICROTI, BORRELIA BURGDORFERI NOSODE, LATRODECTUS MACTANS, CITRICUM ACIDUM, CYTOMEGALOVIRUS NOSODE, RICKETTSIA NOSODE (RICKETTSIA PROWAZEKII), CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE | Bhp Holdings, Inc. | f6186157-256f-4454-b122-f7665e3286f4 | 2023-06-01 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.